Virtual screening for finding natural inhibitor against cathepsin-L for SARS therapy

Summary.Recently Simmons et al. reported a new mechanism for SARS virus entry into target cells, where MDL28170 was identified as an efficient inhibitor of CTSL-meditated substrate cleavage with IC50 of 2.5 nmol/l. Based on the molecule fingerprint searching method, 11 natural molecules were found in the Traditional Chinese Medicines Database (TCMD). Molecular simulation indicates that the MOL376 (a compound derived from a Chinese medicine herb with the therapeutic efficacy on the human body such as relieving cough, removing the phlegm, and relieving asthma) has not only the highest binding energy with the receptor but also the good match in geometric conformation. It was observed through docking studies that the van der Waals interactions made substantial contributions to the affinity, and that the receptor active pocket was too large for MDL21870 but more suitable for MOL736. Accordingly, MOL736 might possibly become a promising lead compound for CTSL inhibition for SARS therapy.

[1]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[2]  Kuo-Chen Chou,et al.  Insights from modeling the 3D structure of H5N1 influenza virus neuraminidase and its binding interactions with ligands. , 2006, Biochemical and biophysical research communications.

[3]  Christian Drosten,et al.  Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome , 2003, Science.

[4]  Kuo-Chen Chou,et al.  Insights from modeling the tertiary structure of human BACE2. , 2004, Journal of proteome research.

[5]  X. L. Liu,et al.  Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern China , 2003, Science.

[6]  Kuo-Chen Chou,et al.  Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS , 2003, Biochemical and Biophysical Research Communications.

[7]  Zhou Jiaju,et al.  Traditional Chinese Medicines: Molecular Structures, Natural Sources, and Applications , 1999 .

[8]  Kuo-Chen Chou,et al.  Modeling the tertiary structure of human cathepsin-E. , 2005, Biochemical and biophysical research communications.

[9]  K. Chou.  Structural bioinformatics and its impact to biomedical science. , 2004, Current medicinal chemistry.

[10]  Guo-Ping Zhou,et al.  Characterization by NMR and molecular modeling of the binding of polyisoprenols and polyisoprenyl recognition sequence peptides: 3D structure of the complexes reveals sites of specific interactions. , 2003, Glycobiology.

[11]  J. Wiseman,et al.  Inhibition of the proteolysis of rat erythrocyte membrane proteins by a synthetic inhibitor of calpain. , 1988, Biochemical and biophysical research communications.

[12]  Robert P. Sheridan,et al.  Chemical Similarity Using Geometric Atom Pair Descriptors , 1996, J. Chem. Inf. Comput. Sci..

[13]  Yvonne C. Martin,et al.  Use of Structure-Activity Data To Compare Structure-Based Clustering Methods and Descriptors for Use in Compound Selection , 1996, J. Chem. Inf. Comput. Sci..

[14]  Guo-Ping Zhou,et al.  NMR study of the preferred membrane orientation of polyisoprenols (dolichol) and the impact of their complex with polyisoprenyl recognition sequence peptides on membrane structure. , 2005, Glycobiology.

[15]  Kuo-Chen Chou,et al.  Prediction of the Tertiary Structure of the β-Secretase Zymogen☆ , 2002 .

[16]  K. Chou,et al.  Prediction of the tertiary structure of a caspase‐9/inhibitor complex , 2000, FEBS letters.

[17]  Kuo-Chen Chou,et al.  Insights from modelling the 3D structure of the extracellular domain of alpha7 nicotinic acetylcholine receptor. , 2004, Biochemical and biophysical research communications.

[18]  G. Gao,et al.  The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Kuo-Chen Chou,et al.  Prediction of the tertiary structure of the beta-secretase zymogen. , 2002, Biochemical and biophysical research communications.

[20]  J. Higaki,et al.  Inhibition of β-amyloid formation identifies proteolytic precursors and subcellular site of catabolism , 1995, Neuron.

[21]  Rolf Hilgenfeld,et al.  Coronavirus Main Proteinase (3CLpro) Structure: Basis for Design of Anti-SARS Drugs , 2003, Science.

[22]  Kuo-Chen Chou,et al.  Coupling interaction between thromboxane A2 receptor and alpha-13 subunit of guanine nucleotide-binding protein. , 2005, Journal of proteome research.

[23]  B. Lenarčič,et al.  Participation of cathepsin L on bone resorption , 1993, FEBS letters.

[24]  M. Mcgrath.  The lysosomal cysteine proteases. , 1999, Annual review of biophysics and biomolecular structure.

[25]  Kuo-Chen Chou,et al.  Application of bioinformatics in search for cleavable peptides of SARS-CoV M(pro) and chemical modification of octapeptides. , 2005, Medicinal chemistry (Shariqah (United Arab Emirates)).

[26]  D. Turk,et al.  Crystal structure of MHC class II‐associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S , 1999, The EMBO journal.

[27]  Kuo-Chen Chou.  Insights from modeling three-dimensional structures of the human potassium and sodium channels. , 2004, Journal of proteome research.

[28]  K D Watenpaugh,et al.  A model of the complex between cyclin-dependent kinase 5 and the activation domain of neuronal Cdk5 activator. , 1999, Biochemical and biophysical research communications.

[29]  S. Diamond,et al.  Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Guo-Ping Zhou,et al.  NMR studies on how the binding complex of polyisoprenol recognition sequence peptides and polyisoprenols can modulate membrane structure. , 2005, Current protein & peptide science.

[31]  Todd J. A. Ewing,et al.  DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases , 2001, J. Comput. Aided Mol. Des..

[32]  Kuo-Chen Chou,et al.  Modelling extracellular domains of GABA-A receptors: subtypes 1, 2, 3, and 5. , 2004, Biochemical and biophysical research communications.